Work

P1.18-05 ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.1321

Authors: G. Durm, S. Althouse, A. Sadiq, S. Jalal, S. Jabbour, R. Zon, G. Kloecker, M. Williamson, K. Reckamp, E. Kio, R. Langdon, B. Adesunloye, R. Gentzler, W. Harb, R. Walling, C. Yeon, M. Koczywas, N. Hanna

Institutions: Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indiana University Health, Indiana University Indianapolis, Fort Wayne Medical Institute, Rutgers Cancer Institute, University of Louisville Hospital, Ball Memorial Hospital, City Of Hope National Medical Center, City of Hope, Goshen Health, University of Virginia, Horizon Oncology Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981643704

FWCI:

Cites:

Cited by: 1

Related to: 10